BioSpace News Archive

Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer will participate in a panel at the Canaccord Genuity Horizons in Oncology Virtual Conference being held April 20, 2023.

Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma ™ Fully Digital Surgical Visualization Platform.

Sensei Biotherapeutics, Inc. today announced that Company management will participate in a panel titled ‘Overcoming Resistance & Immunosuppression in Solid Tumors’ at Canaccord Genuity’s Horizons in Oncology Virtual Conference on Thursday, April 20th at 3:00 p.m. ET.

ATMA Journey Centers Inc. is pleased to announce it has submitted an N500 3,4-Methylenedioxymethamphetamine (MDMA) phase II Clinical Trial Application (CTA) to Health Canada.

Lantern Pharma Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for U.S. patent application no. 17/192,838 directed to Lantern Pharma’s drug candidate LP-284.

Revolo Biotherapeutics announced that management will be presenting at the 8th Food Allergy Fund Summit being held on April 20, 2023, at the Paley Center for Media in New York City.

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its first quarter 2023 financial results on Thursday, April 27, 2023, and provide an update on the commercial launch strategy for obeticholic acid (OCA) in nonalcoholic steatohepatitis (NASH).

Theriva Biologics today announced the presentation of the previously disclosed blinded safety and pharmacokinetic (PK) data from the ongoing Phase 1b/2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase).

BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors.

Atreca, Inc. today announced that John A. Orwin, President and Chief Executive Officer, will be participating in a panel discussion on T-Cells and “Informative B-Cells” at the Canaccord Genuity Horizons in Oncology Virtual Conference.